SCHEMBL10046503

SCHEMBL10046503

CCN(CC(=O)OC)C(=O)CNC(=O)CNC(=O)CN(CC(=O)OC)C(=O)CNC(=O)CNC(=O)OC(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.35
CA14 Q9ULX7 2/20 0.35
CA2 P00918 1/20 0.35
ALDH1A1 P00352 2/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
TSHR P16473 1/20 0.34
RECQL P46063 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
GAA P10253 2/20 0.31
NPFFR1 Q9GZQ6 1/20 0.30
NPFFR2 Q9Y5X5 1/20 0.30
CA1 P00915 1/20 0.30
CA7 P43166 1/20 0.30
CTSK P43235 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15712065 0.93 CA12 (0.35) CA12CA14CA2ALDH1A1MEN1
SCHEMBL15712078 0.93 CA12 (0.35) CA12CA14CA2ALDH1A1MEN1
SCHEMBL409603 0.92 CA12 (0.40) CA12CA14CA2ALDH1A1MEN1
SCHEMBL10046300 0.91 CA12 (0.36) CA12CA14CA2ALDH1A1MEN1
SCHEMBL19204194 0.91 CA12 (0.36) CA12CA14CA2ALDH1A1MEN1
SCHEMBL19579307 0.89 CA12 (0.36) CA12CA14CA2ALDH1A1MEN1
SCHEMBL409105 0.87 CA12 (0.37) CA12CA14CA2ALDH1A1MEN1
SCHEMBL10046507 0.87 CA12 (0.33) CA12CA14CA2ALDH1A1MEN1
SCHEMBL19579098 0.86 MEN1 (0.35) CA12CA14CA2ALDH1A1MEN1
SCHEMBL31041122 0.84 GAA (0.42) CA12CA14CA2ALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8669084-B2 Functional lipid constructs KODE BIOTECH LIMITED (NZ) 2014-03-11 US disclosed
US-20120021430-A1 FUNCTIONAL LIPID CONSTRUCTS KODE BIOTECH LIMITED (NZ) 2012-01-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120021430-A1 FUNCTIONAL LIPID CONSTRUCTS CETP, LCAT, SGMS1 CA12 205/4885CA14 225/4885CA2 1281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.